Medi Speech
Local speech processing with human-confirmed transcription and ClinicalContextEvent generation. No autonomous clinical action.
Clinical Edge AI Prototype Programme
Medi AI+
Development stage
TRL 3 → TRL 4
Current environment
Pre-clinical engineering
Programme objective
Integrated laboratory prototype
Medi AI+ is Provenant AI Labs' flagship R&D programme for locally operated, human-governed clinical AI infrastructure.
Powered by
Medi Knowledge
Governed medical knowledge from approved institutional sources, a Medical Knowledge Graph, retrieval, citations, and refusal mechanisms.
Core Engine
Combines speech-derived context, simulated or device observations, encounter context, governed institutional knowledge, and deterministic safety rules to produce physician-reviewable information.
Edge Runtime
Designed for local or offline execution. Target hardware includes Jetson-class edge computing; final Jetson performance validation is not yet claimed.
Interoperability
FHIR-oriented and integration-ready architecture under development.
Target environment
Hospitals, clinical research environments and healthcare institutions, subject to validation, regulatory assessment and institutional approval.
Public Capabilities
- Higher-acuity clinical workflow support
- Multimodal peripheral integration readiness
- Local observation and escalation documentation support
- Human-in-the-loop clinical operation model
Deployment Use Cases
- High-acuity pilot deployment
- Emergency department workflow support
- Clinical operations validation
Engineering Evidence
- Sprints 0–6 engineering baseline completed
- Current private engineering release: v0.7.0-sprint6
- 394 backend regression tests reported at latest architecture-alignment gate
- AMD64 and ARM64 packaging
- Governed local RAG workflow
- Offline speech engineering workflow
- Synthetic multimodal clinical simulation
- Human-review architecture
- Deterministic safety controls
- Versioned interoperability contracts
- Audit and provenance controls
Engineering evidence does not constitute clinical validation, medical-device certification, regulatory approval or production hospital interoperability.
Read the full engineering statusQualified Enquiry Required
Medi AI+ is a pre-clinical engineering programme. It is not approved for diagnosis, treatment, autonomous clinical decision-making or unsupervised clinical use. Future deployment is subject to engineering validation, institutional review and applicable regulatory requirements.
Pilot & Regulatory Notice
Medi AI+ is currently a pre-clinical engineering programme. Product concepts and pilot configurations shown on this website are for stakeholder evaluation, controlled pilot planning, and qualified commercial discussion only. They are not represented as HSA-registered or approved medical devices, diagnostic systems, treatment systems, autonomous clinical decision-making, or substitutes for professional clinical judgement. It is not approved for diagnosis, treatment, or unsupervised clinical use. Any Singapore deployment must undergo appropriate institutional review, clinical governance, cybersecurity assessment, procurement checks, PDPA/data protection review, and, where applicable, Health Sciences Authority (HSA) medical-device classification, registration, licensing, and approval processes before clinical or operational use.